Post-Marketing Surveillance of Tetravalent Diphtheria-Tetanus-Acellular Pertussis and Inactivated Poliovirus (DTaP-IPV) Vaccine in South Korea, 2009 to 2015

被引：0
|
作者：
Young June Choe
Emmanuel Vidor
Christine Manson
机构：
[1] Medical Affairs,
[2] Sanofi,undefined
[3] Global Medical Affairs,undefined
[4] Sanofi,undefined
[5] Global Pharmacovigilance,undefined
[6] Sanofi,undefined
来源：
Infectious Diseases and Therapy | 2022年 / 11卷
关键词：
Diphtheria; DTaP-IPV; Pertussis; Polio; Post-marketing surveillance; Safety; Tetanus; TETRAXIM™; Vaccines;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：1479 / 1492
页数：13
相关论文
共 46 条
  • [31] Safety and Immunogenicity of Two Formulations of a Hexavalent Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-Haemophilus influenzae Conjugate-Hepatitis B Vaccine in 15 to 18-Month-Old Children
    Halperin, Scott A.
    Langley, Joanne M.
    Hesley, Teresa M.
    Zappacosta, Pamela S.
    Radley, David
    Smith, Bruce
    Hoffenbach, Agnes
    Boslego, John
    Silber, Jeffrey L.
    HUMAN VACCINES, 2005, 1 (06): : 245 - 250
  • [32] Randomized, Controlled, Multicenter Study of the Immunogenicity and Safety of a Fully Liquid Combination Diphtheria-Tetanus Toxoid-Five-Component Acellular Pertussis (DTaP5), Inactivated Poliovirus (IPV), and Haemophilus influenzae Type b (Hib) Vaccine Compared with a DTaP3-IPV/Hib Vaccine Administered at 3, 5, and 12 Months of Age
    Vesikari, Timo
    Silfverdal, Sven Arne
    Boisnard, Florence
    Thomas, Stephane
    Mwawasi, Grace
    Reynolds, Donna
    CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (10) : 1647 - 1653
  • [33] Immunization of preterm infants with GSK's hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity
    Omenaca, Felix
    Vazquez, Liliana
    Garcia-Corbeira, Pilar
    Mesaros, Narcisa
    Hanssens, Linda
    Dolhain, Jan
    Gomez, Ivonne Puente
    Liese, Johannes
    Knuf, Markus
    VACCINE, 2018, 36 (07) : 986 - 996
  • [34] Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age
    Halperin, Scott A.
    Tapiero, Bruce
    Diaz-Mitoma, Francisco
    Law, Barbara J.
    Hoffenbach, Agnes
    Zappacosta, Pamela S.
    Radley, David
    McCarson, Barbara J.
    Martin, Jason C.
    Brackett, Laura E.
    Boslego, John W.
    Hesley, Teresa M.
    Bhuyan, Prakash K.
    Silber, Jeffrey L.
    VACCINE, 2009, 27 (19) : 2540 - 2547
  • [35] Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim™) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of age in infants in South Africa
    Madhi, Shabir Ahmed
    Cutland, Clare
    Jones, Stephanie
    Groome, Michelle
    Ortiz, Esteban
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2011, 101 (02): : 126 - 131
  • [36] Post-Marketing Safety Evaluation of a Tetanus Toxoid, Reduced Diphtheria Toxoid and 3-Component Acellular Pertussis Vaccine Administered to a Cohort of Adolescents in a United States Health Maintenance Organization
    Klein, Nicola P.
    Hansen, John
    Lewis, Edwin
    Lyon, Liisa
    Nguyen, Bessie
    Black, Steven
    Weston, Wayde M.
    Wu, Sterling
    Li, Ping
    Howe, Barbara
    Friedland, Leonard R.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (07) : 613 - 617
  • [37] Immunogenicity and reactogenicity of primary immunization with a novel combined haemophilus influenzae type b and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine coadministered with a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus vaccine at 2, 4 and 6 months
    Tejedor, Juan C.
    Moro, Manuel
    Ruiz-Contreras, Jesus
    Castro, Javier
    Gomez-Campdera, Jose Antonio
    Navarro, Maria Luisa
    Merino, Jose Manuel
    Martin-Ancel, Ana
    Roca, Joan
    Garcia-del-Ri, Manuel
    Jurado, Antonio
    Diez-Delgado, Francisco Javier
    Omenaca, Felix
    Garcia-Sicilia, Jose
    Boceta, Reyes
    Garcia-Corbeira, Pilar
    Collard, Alix
    Boutriau, Dominique
    Schuerman, Lode
    Jacquet, Jeanne-Marie
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (01) : 1 - 7
  • [38] Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12–23 months
    Fred Zepp
    Ulrich Behre
    Klaus Kindler
    Karl-Heinz Laakmann
    Heidemarie Pankow-Culot
    Wilma Mannhardt-Laakmann
    François Beckers
    Dominique Descamps
    Paul Willems
    European Journal of Pediatrics, 2007, 166 : 857 - 864
  • [39] Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months
    Zepp, Fred
    Behre, Ulrich
    Kindler, Klaus
    Laakmann, Karl-Heinz
    Pankow-Culot, Heidemarie
    Mannhardt-Laakmann, Wilma
    Beckers, Francois
    Descamps, Dominique
    Willems, Paul
    EUROPEAN JOURNAL OF PEDIATRICS, 2007, 166 (08) : 857 - 864
  • [40] Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6 and 12-14 months of age
    Diaz-Mitoma, Francisco
    Halperin, Scott A.
    Tapiero, Bruce
    Hoffenbach, Agnes
    Zappacosta, Pamela S.
    Radley, David
    Bradshaw, Susan
    Martin, Jason C.
    Boslego, John W.
    Hesley, Teresa M.
    Bhuyan, Prakash K.
    Silber, Jeffrey L.
    VACCINE, 2011, 29 (06) : 1324 - 1331
12345